BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22728488)

  • 1. Diffuse tubulointerstitial nephritis accompanied by renal crystal formation in an HIV-infected patient undergoing highly active antiretroviral therapy.
    Kanzaki G; Tsuboi N; Miyazaki Y; Yokoo T; Utsunomiya Y; Hosoya T
    Intern Med; 2012; 51(12):1543-8. PubMed ID: 22728488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute tubulointerstitial nephritis in HIV infection].
    Möddel M; Pfammatter R; Varga Z; Keusch G
    Praxis (Bern 1994); 2006 Jun; 95(23):949-51. PubMed ID: 16779906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients.
    Rho M; Perazella MA
    Curr Drug Saf; 2007 May; 2(2):147-54. PubMed ID: 18690961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies.
    Schmid S; Opravil M; Moddel M; Huber M; Pfammatter R; Keusch G; Ambuhl P; Wuthrich RP; Moch H; Varga Z
    Virchows Arch; 2007 Jun; 450(6):665-70. PubMed ID: 17464512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute renal failure in an HIV-positive 50-year-old man.
    Krishnan M; Nair R; Haas M; Atta MG
    Am J Kidney Dis; 2000 Nov; 36(5):1075-8. PubMed ID: 11054370
    [No Abstract]   [Full Text] [Related]  

  • 6. Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study.
    Zaidan M; Lescure FX; Brochériou I; Dettwiler S; Guiard-Schmid JB; Pacanowski J; Rondeau E; Pialoux G; Girard PM; Ronco P; Plaisier E
    Clin J Am Soc Nephrol; 2013 Jun; 8(6):930-8. PubMed ID: 23430209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kidney toxicity's "HAART" therapy].
    Marino A; Ardu F; Dentone C; Secondo G; Ferrea G
    G Ital Nefrol; 2015; 32(5):. PubMed ID: 26480259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute tubulointerstitial nephritis attributable to indinavir therapy.
    Jaradat M; Phillips C; Yum MN; Cushing H; Moe S
    Am J Kidney Dis; 2000 Apr; 35(4):E16. PubMed ID: 10739809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atazanavir nephrotoxicity.
    Hara M; Suganuma A; Yanagisawa N; Imamura A; Hishima T; Ando M
    Clin Kidney J; 2015 Apr; 8(2):137-42. PubMed ID: 25815168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrolithiasis and hydronephrosis in an HIV-infected man receiving tenofovir.
    Cicconi P; Bongiovanni M; Melzi S; Tordato F; d'Arminio Monforte A; Bini T
    Int J Antimicrob Agents; 2004 Sep; 24(3):284-5. PubMed ID: 15325433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kidney disease in HIV-infected patient].
    Matuszkiewicz-Rowińska J; Wieliczko M
    Wiad Lek; 2016; 69(5):725-728. PubMed ID: 28033595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic interstitial nephritis in an HIV type-1-infected patient receiving ritonavir-boosted atazanavir.
    Viglietti D; Verine J; De Castro N; Scemla A; Daudon M; Glotz D; Pillebout E
    Antivir Ther; 2011; 16(1):119-21. PubMed ID: 21311116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms associated with renal adverse effects of antiretroviral therapy in a Southern Brazilian HIV cohort.
    da Rocha IM; Gasparotto AS; Lazzaretti RK; Notti RK; Sprinz E; Mattevi VS
    Pharmacogenet Genomics; 2015 Nov; 25(11):541-7. PubMed ID: 26287941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced acute interstitial nephritis mimicking acute tubular necrosis after initiation of tenofovir-containing antiretroviral therapy in patient with HIV-1 infection.
    Nishijima T; Yazaki H; Hinoshita F; Tasato D; Hoshimoto K; Teruya K; Gatanaga H; Kikuchi Y; Oka S
    Intern Med; 2012; 51(17):2469-71. PubMed ID: 22975570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute interstitial nephritis with predominant plasmacytic infiltration in patients with HIV-1 infection.
    Melica G; Matignon M; Desvaux D; Audard V; Copie-Bergman C; Lang P; Levy Y; Grimbert P
    Am J Kidney Dis; 2012 May; 59(5):711-4. PubMed ID: 22342319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of renal stones among HIV-infected patients on ritonavir-boosted atazanavir than in those receiving other protease inhibitor-containing antiretroviral therapy.
    Hamada Y; Nishijima T; Watanabe K; Komatsu H; Tsukada K; Teruya K; Gatanaga H; Kikuchi Y; Oka S
    Clin Infect Dis; 2012 Nov; 55(9):1262-9. PubMed ID: 22820542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal manifestations in HIV-infected Jamaican children.
    Steel-Duncan J; Miller M; Pierre RB; Dunkley-Thompson J; Palmer P; Evans-Gilbert T; Rodriquez B; Christie CD;
    West Indian Med J; 2008 Jun; 57(3):246-52. PubMed ID: 19583123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotoxicity of antiretroviral therapy in an HIV-infected patient.
    Said SM; Nasr SH; Samsa R; Markowitz GS; D'Agati VD
    Kidney Int; 2007 May; 71(10):1071-5. PubMed ID: 17311070
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diffuse infiltrative lymphocytosis syndrome: another cause of acute renal failure in the HIV-infected patient].
    Sidahi M; Luque R; Martínez A; Mañas MD
    Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):757-8. PubMed ID: 20880610
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection.
    Wyatt CM; Klotman PE
    Expert Opin Drug Saf; 2006 Mar; 5(2):275-87. PubMed ID: 16503748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.